Synthesis and biological evaluation of 1,2-dihydro-2,11B-diazabenzo[de]anthracen-one derivatives as potent poly(ADP-ribose) polymerase (PARP-1) inhibitors.

被引：0
|
作者：
Xu, WZ [1 ]
Chen, J [1 ]
Grella, B [1 ]
Ko, YS [1 ]
Huang, S [1 ]
Lauter, S [1 ]
Li, JH [1 ]
Liu, Q [1 ]
Williams, L [1 ]
Wu, QY [1 ]
Zhang, J [1 ]
Kalish, V [1 ]
机构：
[1] Guilford Pharmaceut Inc, Baltimore, MD 21224 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2004年 / 227卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
016-MEDI
引用
收藏
页码：U7 / U7
页数：1
相关论文
共 50 条
  • [41] Design and Synthesis of N-Substituted Indazole-3-Carboxamides as Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors
    Patel, Maulik R.
    Pandya, Kashyap G.
    Lau-Cam, Cesar A.
    Singh, Satyakam
    Pino, Maria A.
    Billack, Blase
    Degenhardt, Kurt
    Talele, Tanaji T.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 79 (04) : 488 - 496
  • [42] A mechanistic approach to understand the allosteric reverse signaling by selective and trapping poly(ADP-ribose) polymerase 1 (PARP-1) inhibitors
    Kumar, Chandan
    Lakshmi, P. T. V.
    Arunachalam, Annamalai
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (08): : 2482 - 2492
  • [43] Synthesis and evaluation of a new series of spiro aryl dioxolane compounds: A new scaffold as potential poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors
    Maigali, Soher S.
    El-Shanawany, Hala R.
    El-Sayed, Naglaa F.
    Youssef, Mohamed A.
    Fouad, Marwa A.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2022, 59 (11) : 1944 - 1962
  • [44] Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Diabetic Retinopathy: An Attractive but Elusive Choice for Drug Development
    Postyeni, Etelka
    Gabriel, Robert
    Kovacs-Valasek, Andrea
    PHARMACEUTICS, 2024, 16 (10)
  • [45] An in silico protocol for identifying potential poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors from chemical databases
    Niu, Miaomiao
    Gu, Yueqing
    NEW JOURNAL OF CHEMISTRY, 2015, 39 (02) : 1060 - 1066
  • [46] Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors
    Orvieto, Federica
    Branca, Danila
    Giomini, Claudia
    Jones, Philip
    Koch, Uwe
    Ontoria, Jesus M.
    Palumbi, Maria Cecilia
    Rowley, Michael
    Toniatti, Carlo
    Muraglia, Ester
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4196 - 4200
  • [47] Synthesis and structure-activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)
    Wells, GJ
    Bihovsky, R
    Hudkins, RL
    Ator, MA
    Husten, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (05) : 1151 - 1155
  • [48] Poly [ADP-Ribose] Polymerase 1 (PARP-1) Expression Before and After Immunochemotherapy In Patients With B Chronic Lymphocytic Leukemia
    Diamantopoulos, Panagiotis Theodorou
    Sofotasiou, Maria
    Papadopoulou, Vasiliki
    Polonyfi, Katerina
    Iliakis, Theodoros
    Kalala, Fani
    Zervakis, Konstantinos
    Rougala, Niki
    Giannakopoulou, Nefeli
    Hatzinikolaou, Xenia
    Galanopoulos, Athanassios
    Variami, Eleni
    Pangalis, Gerassimos A.
    Viniou, Nora-Athina
    BLOOD, 2013, 122 (21)
  • [49] DESIGN AND SYNTHESIS OF NOVEL POLY ADP-RIBOSE POLYMERASE 1 (PARP1) INHIBITORS FOR THE TREATMENT OF SOLID TUMORS
    Priyancy, J.
    Bhumika, D. P.
    CONFERENCE ON DRUG DESIGN AND DISCOVERY TECHNOLOGIES, 2020, 355 : 31 - 35
  • [50] N1-Substituted indazole-3-carboxamides as novel inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)
    Patel, Maulik R.
    Kulkarni, Shridhar
    Pino, Maria
    Billack, Blase
    Talele, Tanaji T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
12345